Sufentanil Sublingual Tablet Can Reduce Patient Reliance on IV OpioidsByJames Miner, MDJanuary 29th 2019The soon-to-be marketed therapy Dsuvia has shown enough benefit, tolerability, and safety to aid an at-need patient population in a controlled setting.